IMFINZI
IMFINZI
Approved
DIN Number
02468816
Drug Class
Human
Market Date
Nov 20, 2017
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02468816
AIG Number0159570001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FF03 DURVALUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DURVALUMABActive
Strength: 50 MG / ML
Monograph: DURVALUMAB